Cargando…

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy

BACKGROUND: IDSA guidelines for invasive candidiasis recommend echinocandins (ECH) as first-line agents for initial therapy, with fluconazole (FLU) as an acceptable alternative. Transitioning from an ECH to FLU is also recommended in clinically stable patients with FLU susceptible isolates. All-caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Box, Maggie, Anwar, Lara, Molina, Kyle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678670/ http://dx.doi.org/10.1093/ofid/ofad500.853

Ejemplares similares

2237. Outcomes of Metronidazole Dosed Every 12 Hours Versus Every 8 Hours
por: Box, Maggie, et al.
Publicado: (2023)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

P27 Rezafungin treatment of candidaemia and invasive candidiasis: outcomes stratified by baseline renal function—analysis of the Phase 2 + Phase 3 trials
por: Sandison, Taylor, et al.
Publicado: (2023)

Breakthrough Invasive Candidiasis in Children
por: Dong, Sara, et al.
Publicado: (2017)

Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
por: Cahan, Heather, et al.
Publicado: (2011)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

Utility of Serial β-d-Glucan Levels in Patients with High Risk for Invasive Candidiasis: A Potential Tool for Antifungal Stewardship
por: Chua, Alvin Qijia, et al.
Publicado: (2017)

Conventional and alternative antifungal therapies to oral candidiasis
por: Anibal, Paula Cristina, et al.
Publicado: (2010)

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
por: Honarvar, Behnam, et al.
Publicado: (2018)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Candidiasis and Mechanisms of Antifungal Resistance
por: Bhattacharya, Somanon, et al.
Publicado: (2020)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

1688. Invasive Ocular Candidiasis: Who Is Really at Risk?
por: Seidelman, Jessica, et al.
Publicado: (2019)

808. Perinatal Depression Among HIV- and TB-Infected and Uninfected Women in an Urban Slum in India: Prevalence and Associated Birth Outcomes
por: Grossman, Tracy, et al.
Publicado: (2018)

2037. Utilization of the T2 Magnetic Resonance in the Early Detection of Invasive Candidiasis
por: Patel, Sonal, et al.
Publicado: (2018)

Treatment of invasive candidiasis with caspofungin in the intensive care unit
por: DiNubile, MJ, et al.
Publicado: (2003)

808. Evaluating the Incidence of Bacteriuria in Female Patients Before and After Implementation of External Catheter Devices
por: Noval, Mandee, et al.
Publicado: (2020)

Epidemiological cohort study of systemic antifungal therapy for suspected or confirmed invasive candidiasis in the ICU: the Amarcand2 study
por: Constantin, J, et al.
Publicado: (2015)

2033. Incorporating T2Candida Testing into Rational Antifungal (AF) Management: A Successful Pilot Study of Diagnostic Stewardship (DS) Directed Toward Specific Intensive Care Unit (ICU) Patients At-Risk for Sepsis due to Invasive Candidiasis (IC)
por: Shields, Ryan K, et al.
Publicado: (2018)

380. Drosophila melanogaster as a Facile Model for Large-Scale Studies of Virulence Mechanisms and Antifungal Drug Efficacy in Candida auris Candidiasis
por: Bandi, Ashwini, et al.
Publicado: (2018)

1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin Resistance
por: Clancy, Cornelius J, et al.
Publicado: (2019)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

170 Outcomes of Rapid Identification for Gram Positive Bacteremia in Combination with Antibiotic Stewardship at a Community Based Hospital System
por: Box, Maggie
Publicado: (2014)

Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
por: Ou, Huang-Tz, et al.
Publicado: (2017)

Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis
por: Parslow, Ben Y., et al.
Publicado: (2022)

808. Appropriate Use of Cephalotin Before and After Implementation of a Cardiac Surgery Antibiotic Prophylaxis Protocol in Guatemala
por: Maldonado, Herberth G, et al.
Publicado: (2021)

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy
por: Dekkers, B. G. J., et al.
Publicado: (2018)

Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
por: Lírio, Juliana, et al.
Publicado: (2019)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021)

Probiotics to Reduce Clostridium difficile Infection: Clinical Experience in a Tertiary Care Center
por: Box, Maggie, et al.
Publicado: (2017)

Antifungal stewardship in critical care: Implementing a diagnostics-driven care pathway in the management of invasive candidiasis
por: Hare, D., et al.
Publicado: (2020)

The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
por: Ordaya, Eloy E., et al.
Publicado: (2023)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates
por: Mohammadi, R, et al.
Publicado: (2016)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis
por: Min, Yang Won, et al.
Publicado: (2015)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

1701. Trends in Invasive Candidiasis in Children with Hematologic Malignancies: Increased Risk of Dissemination with Non-albicans Candida
por: Said, Amira, et al.
Publicado: (2023)

635. Is Azole Prophylaxis in Liver Transplant Recipients Effective in Preventing Invasive Candidiasis in the Era of Emerging Resistance?
por: Gurram, Pooja R, et al.
Publicado: (2022)

824. Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience
por: Lu, Brian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8186lanhdupn98iv5opkf4aqne